Regulatory Affairs

A network of experts
who share our values

RECENT POSTS

Our expertise

We support you at every stage in the process of optimizing your organization and improving your Quality Management System, from one-off consultancy assignments to long-term support. Our aim is to be responsive, pragmatic and operational. We can also offer you out-sourcing services for some of your activities.

\n

- Compliance with the law governing benefits and transparency of links of interest<\/p>\n <\/div>\n

\n
    \n
  • Support you, in these same areas, in carrying out your technical Due Diligences (mergers, acquisitions, fund-raising, etc.), in the expert examination of your technical specifications with your subcontractors or other service providers.<\/li>\n <\/ul>\n<\/div>\n
    \n\t
    OUR PROMISE<\/strong>
    <\/div>\n\t
      \n
    • An independent, expert view of your organization and your objectives<\/li>\n <\/ul><\/div>\n
      \n
      OUR RESOURCES<\/strong> <\/div>\n
        \n
      • Our network of highly experienced auditors<\/li>\n
      • With strong operational experience of the activities audited<\/li>\n
      • Working in pairs: Quality Expert\/Business Expert
        \n <\/li>\n <\/ul>\n <\/div>\n
        \n
        OUR COMMITMENT<\/strong><\/div>\n
          \n
        • A harmonized audit process for all auditors<\/li>\n
        • The same non-conformities analysis criteria<\/li>\n
        • Quality control of the audit report by another auditor
          \n <\/li>\n <\/ul>\n <\/div>\n<\/div>","customeCssCode":".imh-6310-custom-temp-05 {\n width: 420px;\n background: #ffffff;\n font-family: \"IBM Plex Sans\", sans-serif;\nfont-color:#123250;\n text-align: left;\n padding: 0 0 10px;\n margin: 0 auto 10px;\n border-radius: 10px;\n box-shadow: 0 0 10px rgba(0, 0, 0, 0.15);\n position: relative;\n\t\n}\n\n.bordure {\n border: 2px solid #4cbbb8;\n padding: 5px;\n border-radius: 15px;\n\twidth: 150px;\n\tbackground: #4cbbb8;\n font-family: \"IBM Plex Sans\", sans-serif;\nfont-color:#123250;\n text-align: left;\n}\n\n.bloc {\n margin-left: 50px;\nline-height: 13px;\n}\n\n.imh-6310-custom-temp-05 .imh-6310-custom-temp-05-title {\n color: #fff;\n background: linear-gradient(to right, #123250, #4cbbb8);\n text-align: center;\nfont-size: 14px;\n font-weight: 400;\n padding: 5px 0 5px 0;\n margin: 0 auto 10px;\n font-family: \"IBM Plex Sans\", sans-serif;\n border-radius: 10px 10px 0 0;\n display: block;\n}\n\n.imh-6310-custom-temp-05 .imh-6310-custom-temp-05-description {\n\n font-family: \"IBM Plex Sans\", sans-serif;\ncolor:#123250;\n font-size: 11px;\nfont-weight:300;\n line-height: 12px;\nletter-spacing: 0.5px;\n margin: 0 10px 10px 5px;\n padding: 0 15px;\n}\n\n.imh-6310-custom-temp-05 .imh-6310-custom-temp-05-icon {\n color: #fff;\n background: linear-gradient(to right, #19bbd2, #2778ee);\n font-size: 40px;\n line-height: 100px;\n width: 130px;\n height: 130px;\n margin: 0 auto;\n border-radius: 10px;\n overflow: hidden;\n outline: 6px solid #00203f;\n box-shadow: 0 0 9px 6px white;\n}\n\n.imh-6310-custom-temp-05-icon img {\n width: 100%;\n float: left;\n}\n\n\n@media screen and (max-width:990px) {\n .imh-6310-custom-temp-05 {\n margin-bottom: 35px;\n }\n}","customeCodePopup":"","popupCustomHtml":"","popupCustomCss":"","popupCustomCodeWidth":"","customIconLinkType":"2","elementType":3,"xPos":"21.32","yPos":"40.66","tWidth":"1485.671875","iconWidth":"30"}' class='imh-6310-drag imh-6310-point-3-1' style='display: none'>
        Tooltip text
        <\/br>\n
      • Conduct a risk analysis of an activity, process or organization and implement a risk management plan.<\/li><\/br>\n <\/ul>\n <\/div>\n\n
        \n
        WE HELP YOU MEET<\/strong><\/div>\n<\/div>\n
        \n
          \n
        • Your needs<\/li><\/br>\n
        • Your constraints<\/li><\/br>\n
        • Your risks<\/li><\/br>\n<\/div><\/div>","customeCssCode":".imh-6310-custom-temp-05 {\n width: 420px;\n background: #ffffff;\n font-family: \"IBM Plex Sans\", sans-serif;\nfont-color:#123250;\n text-align: left;\n padding: 0 0 10px;\n margin: 0 auto 10px;\n border-radius: 10px;\n box-shadow: 0 0 10px rgba(0, 0, 0, 0.15);\n position: relative;\n\t\n}\n\n.bordure {\n border: 2px solid #4cbbb8;\n padding: 5px;\n border-radius: 15px;\n\twidth: 150px;\n\tbackground: #4cbbb8;\n font-family: \"IBM Plex Sans\", sans-serif;\nfont-color:#123250;\n text-align: left;\n}\n\n.bordure2 {\n border: 2px solid #4cbbb8;\n padding: 5px;\n border-radius: 15px;\n\twidth: 220px;\n\tbackground: #4cbbb8;\n font-family: \"IBM Plex Sans\", sans-serif;\nfont-color:#123250;\n text-align: left;\n}\n\n.bloc {\n margin-left: 50px;\n}\n\n.imh-6310-custom-temp-05 .imh-6310-custom-temp-05-title {\n color: #fff;\n background: linear-gradient(to right, #123250, #4cbbb8);\n text-align: center;\nfont-size: 14px;\n font-weight: 400;\n padding: 5px 0 5px 0;\n margin: 0 auto 10px;\n font-family: \"IBM Plex Sans\", sans-serif;\n border-radius: 10px 10px 0 0;\n display: block;\n}\n\n.imh-6310-custom-temp-05 .imh-6310-custom-temp-05-description {\n\n font-family: \"IBM Plex Sans\", sans-serif;\ncolor:#123250;\n font-size: 11px;\nfont-weight:300;\n line-height: 12px;\nletter-spacing: 0.5px;\n margin: 0 10px 10px 5px;\n padding: 0 15px;\n}\n\n.imh-6310-custom-temp-05 .imh-6310-custom-temp-05-icon {\n color: #fff;\n background: linear-gradient(to right, #19bbd2, #2778ee);\n font-size: 40px;\n line-height: 100px;\n width: 130px;\n height: 130px;\n margin: 0 auto;\n border-radius: 10px;\n overflow: hidden;\n outline: 6px solid #00203f;\n box-shadow: 0 0 9px 6px white;\n}\n\n.imh-6310-custom-temp-05-icon img {\n width: 100%;\n float: left;\n}\n\n\n@media screen and (max-width:990px) {\n .imh-6310-custom-temp-05 {\n margin-bottom: 35px;\n }\n}","customeCodePopup":"","popupCustomHtml":"","popupCustomCss":"","popupCustomCodeWidth":"","customIconLinkType":"2","elementType":3,"xPos":"80.65","yPos":"60.77","tWidth":"1485.671875","iconWidth":"30"}' class='imh-6310-drag imh-6310-point-3-2' style='display: none'>
        Tooltip text
        Tooltip text
Who's who?

In 2009, Marie-Christine Belleville and Laurent Clerc set up Belleville PharmExperts to offer manufacturers a highly flexible approach, at the heart of their companies and projects. Drawing on both their operational and managerial experience, they offer healthcare companies the benefit of their regulatory expertise, quality culture and in-depth knowledge of software tools.

img
img
Marie-Christine Belleville

Member of the ‘Académie nationale de Pharmacie’ (Pharmaceutical and legal sciences section applied to the industrial environment of medicines and other health products), author and coordinator of the "Indisponibilité des médicaments" report (June 20, 2018) and the "Risques sanitaires et éthiques liés à l'innovation thérapeutique" report (October 2005). Head of the AFAR Promotional Information Charter Working Group since its creation in 2005 and Co-Head of the Professional Practices Charter Working Group (medical devices). A pharmacist and former hospital intern, Marie-Christine Belleville has over 40 years' professional experience in the pharmaceutical industry, within the industry, the professional body (LEEM) and consulting firms in pharmaceutical regulatory affairs and quality management (25 years). She holds a post-graduate diploma (DESS) in drug control and plant drugs, and a post-graduate diploma (DESS) in pharmaceutical legislation and ethics.

img
img
Laurent Clerc

A Doctor of Pharmacy with a post-graduate diploma (DESS) in Health Law, a DESS in Quality Assurance and an Executive Master of Business Administration from ESCP-Europe, Laurent Clerc has more than 25 years' professional experience in the pharmaceutical industry and hospital structures, in pharmaceutical regulatory affairs consultancies and as manager of a software publisher specializing in Compliance. For 10 years, he set up and managed the ISO 9001 Quality Management System for this software publisher. He also has practical experience of organizing and managing outsourcing services for the healthcare industry.

our partners

In addition to the regulatory requirements we cover for your structure and your healthcare products, depending on their status (drug or medical device), we offer you the following privileged partners to enable you to contact a network of experts who share our values of responsiveness, rigor and pragmatism.

  • icon

    Cabinet LCH - Avocats

    The firm assists all players in the healthcare sector: pharmaceutical companies, DMD and DMDIV manufacturers, cosmetics companies, the agri-food industry, CROs, authorized healthcare data hosts, healthcare marketing agencies, trade associations and insurance companies.

    For over 20 years, LCH has been the reference for healthcare industries seeking regulatory advice and assistance in implementing healthcare compliance obligations: LEA and transparency.

    LCH assists companies of all sizes, from new entrants to listed companies, both French and international.

    We also organize customized training courses for your teams on the legal issues facing your industries.

    Our expertise enables us to support you throughout your projects, both in France and in your international development, thanks to our network of foreign firms specialized in LifeSciences.

    SITE WEB
  • icon

    PHARMÈS

    𝗦𝗼𝗰𝗶𝗲́𝘁𝗲́ 𝗱𝗲 𝗰𝗼𝗻𝘀𝗲𝗶𝗹 dynamic and expert in the field of Regulatory Affairs for the health industries for 15 years.
    𝗣𝗵𝗮𝗿𝗺𝗲̀𝘀 𝗳𝗮𝗶𝘁 𝗽𝗮𝗿𝘁𝗶𝗲 𝗱'𝘂𝗻 𝗿𝗲́𝘀𝗲𝗮𝘂 𝗲𝘂𝗿𝗼𝗽𝗲́𝗲𝗻 𝗱𝗲 𝗰𝗼𝗻𝘀𝘂𝗹𝘁𝗮𝗻𝘁𝘀 experts in the field of healthcare products: 𝗿𝗲𝗴𝘂𝗹𝗮𝗻𝗲𝘁

    𝗩𝗘𝗜𝗟𝗟𝗘𝗦 : 𝗨𝗻 𝘀𝗲𝗿𝘃𝗶𝗰𝗲 𝘂𝗻𝗶𝗾𝘂𝗲 𝗲𝗻 𝗙𝗿𝗮𝗻𝗰𝗲: A single database bringing together:
    - 𝗩𝗲𝗶𝗹𝗹𝗲 𝗿𝗲́𝗴𝗹𝗲𝗺𝗲𝗻𝘁𝗮𝗶𝗿𝗲 (𝗥𝗘𝗚'𝗘𝗩𝗔𝗟): Monitoring and analysis of texts, recommendations, doctrines, case law relating to Health Products in France and Europe, (information and analysis database + weekly Newsletters)
    - 𝗩𝗲𝗶𝗹𝗹𝗲 𝗣𝗿𝗼𝗱𝘂𝗶𝘁𝘀 (𝗠𝗘𝗗'𝗘𝗩𝗔𝗟): The history of a drug since the 1st evaluations..(possibility of creating a personalized alert by therapeutic area).

    𝗗𝗢𝗦𝗦𝗜𝗘𝗥𝗦
    Audit and drafting of dossiers:
    - MA,
    - pharmaceutical or clinical variations
    - delisting,
    - direct access applications,
    - IMPD
    - transparency and price
    - early access

    𝗥𝗘́𝗗𝗔𝗖𝗧𝗜𝗢𝗡 𝗗𝗘 𝗣𝗥𝗢𝗖𝗘́𝗗𝗨𝗥𝗘𝗦 𝗘𝗫𝗣𝗟𝗢𝗜𝗧𝗔𝗡𝗧

    𝗖𝗢𝗡𝗦𝗘𝗜𝗟
    Analysis of your projects and advice:
    - Advertising,
    - Personal data protection,
    - Registration and variation strategy,
    - European regulations (pharmacovigilance, clinical trials, pediatrics, orphans)
    - Clinical trials

    SITE WEB
touch-illustration
Contact us

Let's discuss your projects...


    The above data is collected by BELLEVILLE PHARMEXPERTS in order to process and monitor your request. To find out more about the management of your personal data and to exercise your rights, refer to our legal notices.